Old Web
English
Sign In
Acemap
>
Paper
>
Evidence From the North Carolina Medicaid Program Direct Cost Analyses of Palivizumab Treatment in a Cohort of At-Risk Children:
Evidence From the North Carolina Medicaid Program Direct Cost Analyses of Palivizumab Treatment in a Cohort of At-Risk Children:
2011
William Campbell
Alan D. Stiles
Steven E. Wegner
Julie C. Jacobson Vann
Gordon G. Liu
Patricia J. Byrns
Clement Cypra
Keywords:
Cohort
Environmental health
Family medicine
Medicaid Program
Palivizumab
Medicine
direct cost
Correction
Cite
Save
Machine Reading By IdeaReader
25
References
0
Citations
NaN
KQI
[]